Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras

被引：0
作者：
Ilerhunmwuwa, Nosakhare Paul [1 ]
Rayapureddy, Aditya Keerthi [2 ]
Uche, Ifeanyi Nnamdi [1 ]
Wasifuddin, Mustafa [3 ]
Wang, Jen-Chin [4 ]
机构：
[1] Brookdale Univ Hosp & Med Ctr, Dept Med, Brooklyn, NY USA
[2] Interfaith Med Ctr, Dept Med, Brooklyn, NY USA
[3] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY USA
[4] Brookdale Univ Hosp & Med Ctr, Div Hematol Oncol, Brooklyn, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] SURVIVAL AND RISK OF DEATH ANALYSIS OF PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
    Stoeva, V
    Mihaylov, G.
    Tachkov, K.
    Petrova, G.
    VALUE IN HEALTH, 2023, 26 (12) : S248 - S248
  • [22] Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study
    Koyuncu, Mahmut B.
    Ilgan, Mustafa
    Basir, Hakan
    Tombak, Anil
    Ucar, Mehmet Ali
    Koseci, Tolga
    Akdeniz, Aydan
    Tiftik, Eyup N.
    Erel, Ozcan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [23] The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib
    Dass, Jasmita
    Langer, Sabina
    Kotwal, Jyoti
    Gupta, Nitin
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (01) : 186 - 188
  • [24] Cryptococcal infection with ruxolitinib in primary myelofibrosis: A case report and literature review
    Ciochetto, Zachary
    Wainaina, Njeri
    Graham, Mary Beth
    Corey, Anna
    Abid, Muhammad Bilal
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [25] Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis
    Chen, Yen-Hao
    Lee, Chen-Hsiang
    Pei, Sung-Nan
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1528 - 1529
  • [26] Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis
    Paolo Strati
    Maen Abdelrahim
    Umut Selamet
    Valda D. Page
    Sherry A. Pierce
    Srdan Verstovsek
    Ala Abudayyeh
    Annals of Hematology, 2019, 98 : 1611 - 1616
  • [27] Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib
    Rajasekaran, Arun
    Thuy-Trang Ngo
    Abdelrahim, Maen
    Glass, William
    Podoll, Amber
    Verstovsek, Srdan
    Abudayyeh, Ala
    BMC NEPHROLOGY, 2015, 16
  • [28] The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib
    Jasmita Dass
    Sabina Langer
    Jyoti Kotwal
    Nitin Gupta
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 186 - 188
  • [29] Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib
    Branco, Benoit
    Metsu, David
    Dutertre, Marine
    Marchou, Bruno
    Delobel, Pierre
    Recher, Christian
    Martin-Blondel, Guillaume
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1207 - 1209
  • [30] Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis
    Strati, Paolo
    Abdelrahim, Maen
    Selamet, Umut
    Page, Valda D.
    Pierce, Sherry A.
    Verstovsek, Srdan
    Abudayyeh, Ala
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1611 - 1616
12345